<DOC>
	<DOC>NCT00213109</DOC>
	<brief_summary>The purpose of this study is evaluate the clinical efficacy and safety of Miglitol in patients with Type1 Diabetes Mellitus treated with insulin.</brief_summary>
	<brief_title>Open Trial of Miglitol in Type 1 Diabetic Patients With Insulin Treatment</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 1</mesh_term>
	<mesh_term>Miglitol</mesh_term>
	<criteria>Type1 Diabetes Criteria of postprandial glucose and HbA1c are met Type2 Diabetes Patients with antidiabetic drugs The other exclusion criteria are met</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>alpha-glucosidase inhibitor,Insulin</keyword>
</DOC>